Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 1
2012 2
2013 1
2014 5
2016 3
2017 4
2018 9
2019 12
2020 60
2021 102
2022 96
2023 46
2024 33
2025 29
2026 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alessandro r izzo (3 results)?
Microbiota and prostate cancer.
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Rizzo A, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):1058-1065. doi: 10.1016/j.semcancer.2021.09.007. Epub 2021 Sep 15. Semin Cancer Biol. 2022. PMID: 34536504 Review.
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment.
De Luca R, Gianotti L, Pedrazzoli P, Brunetti O, Rizzo A, Sandini M, Paiella S, Pecorelli N, Pugliese L, Pietrabissa A, Zerbi A, Salvia R, Boggi U, Casirati A, Falconi M, Caccialanza R. De Luca R, et al. Among authors: rizzo a. Eur J Surg Oncol. 2023 Mar;49(3):542-549. doi: 10.1016/j.ejso.2022.12.006. Epub 2022 Dec 22. Eur J Surg Oncol. 2023. PMID: 36577556 Review.
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.
Santoni M, Büttner T, Rescigno P, Fiala O, Cavasin N, Basso U, Taha T, Massari F, Myint ZW, Formisano L, Galli L, Scagliarini S, Matrana MR, Facchini G, Bamias A, Messina C, Zacchi F, Manneh RK, Roviello G, Santini D, Poprach A, Navratil J, Uher M, Calabrò F, Pierce E, Berardi R, Aurilio G, Zakopoulou R, Rizzo A, Ansari J, Rizzo M, Bisonni R, Mollica V, Incorvaia L, Spinelli G, Jiang XY, Chandler RA, Grillone F, Morelli F, Buti S, Maluf FC, Marques Monteiro FS, Battelli N, Porta C, Caffo O, Soares A. Santoni M, et al. Among authors: rizzo a. Eur Urol Oncol. 2025 Apr;8(2):444-451. doi: 10.1016/j.euo.2024.11.005. Epub 2024 Nov 29. Eur Urol Oncol. 2025. PMID: 39613567 Free article.
Editors' Choice 2025.
Liu P, Coatsworth P, Neto P, Tian L, de Carvalho Castro E Silva C, Huang C, Daw R, Elias S, Behnood A, Schofield JS, Rizzo A, Perlman O, Raney J, Chen WG, Fujii M, Tingley DD, Wang W, Mastrangeli M. Liu P, et al. Among authors: rizzo a. Commun Eng. 2026 Feb 11;5(1):27. doi: 10.1038/s44172-026-00594-8. Commun Eng. 2026. PMID: 41673097 Free PMC article.
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.
Porta C, Massari F, Taha T, Grande E, Bourlon MT, Kanesvaran R, Basso U, Molina-Cerrillo J, Alonso-Gordoa T, Myint ZW, Fornarini G, Buttner T, Park SH, Ürün Y, De Giorgi U, Pichler R, Rescigno P, Buchler T, Studentova H, Melichar B, Ansari J, Mollica V, Kucharz J, Rizzo M, Rizzo A, Kopp RM, Buti S, Monteiro FSM, Soares A, Bamias A, Santoni M. Porta C, et al. Among authors: rizzo a. Cancer Immunol Immunother. 2025 May 9;74(7):196. doi: 10.1007/s00262-025-04019-x. Cancer Immunol Immunother. 2025. PMID: 40343572 Free PMC article.
393 results